Advanced Oncotherapy #AVO – Completion of the Subscription Agreement
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that in relation to the announcement dated 7 December 2017 and following the passing of the resolution proposed for the vote of the Company’ shareholders on 23 January 2018, the Company has been informed by Yantai Cipu that the Chinese […]
Advanced Oncotherapy #AVO – Result of GM
Advanced Oncotherapy plc (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that at the General Meeting held earlier today, all resolutions were duly passed. For further information contact: Advanced Oncotherapy Plc www.avoplc.com Dr. Michael Sinclair, Executive Chairman Tel: +44 20 3617 8728 Nicolas Serandour, CEO Stockdale Securities (Nomad & Joint Broker) Antonio Bossi […]
Advanced Oncotherapy #AVO – Dr Enrico Vanni director dealing
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that yesterday Dr Enrico Vanni, Non-Executive Director of the Company purchased 40,000 ordinary shares of 25 pence in the Company at a price of 54.5 pence per Ordinary Share. Following this transaction, Dr Vanni now holds 1,263,946 Ordinary Shares, representing 1.56% of the […]
Stocktube – Brand Communications’ Alan Green highlights his small cap stocks to watch in 2018.
Brand Communications’ Alan Green highlights his small cap stocks to watch in 2018. First on Alan’s hit list is Tertiary Minerals (LON:TYM). Tertiary’s share price has been on a good run recently since it announced they’d signed an MoU with global commodities group Possehl to enter into an offtake agreement to support the […]
Advanced Oncotherapy #AVO – Notice of General Meeting
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that a circular convening the Company’s General Meeting to be held at the Royal Institute of British Architects, 66 Portland Place, London W1B 1AD at 10:00am on Tuesday, 23 January 2018, in relation to the transactions announced on 7 December 2017 has […]
Advanced Oncotherapy #AVO – LIGHT accelerator and Harley Street construction on track and on target
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it remains on schedule with the development of the first LIGHT system, as per the timetable provided to shareholders on 6 March 2017, and provides the following technological update: The Company continues to make significant advancements in the technology […]
Brand CEO Alan Green talks #TYM, #PDZ, #AVO, #KDNC and crypto with Andrew Scott on Proactive Investors
Brand CEO Alan Green talks Tertiary Minerals #TYM, Prairie Mining #PDZ, Advanced Oncotherapy #AVO, Cadence Minerals #KDNC and crypto currency with Andrew Scott at Proactive Investors
Nicolas Serandour, CEO of Advanced Oncotherapy #AVO talks to Andrew Scott at Proactive Investors
Nicolas Serandour, CEO of Advanced Oncotherapy #AVO, visited the Proactive Investors studio to add some extra detail to their recent announcement that they’ve secured £37.4mln of fresh funding – £30mln of this coming from a new Chinese investor.
Advanced Oncotherapy #AVO – Hardman Research: Distribution agreement and capital increase
Advanced Oncotherapy #AVO – Hardman Research: Distribution agreement and capital increase Distribution agreement and capital increase: AVO is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world-renowned CERN. Major milestones have been achieved in 2017 and the company remains on track with its development plan to deliver […]
Nicolas Serandour, CEO of Advanced Oncotherapy #AVO discusses Yantai deal & £37m equity investment with BRR Media
Nicolas Serandour, CEO of Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, announces that they have signed an exclusive distribution agreement with Yantai CIPU Medical Technology to market and sell Advanced Oncotherapy’s LIGHT system across China, Macau, Taiwan, Hong-Kong and South Korea. At the same time, the Company has secured £20.9 […]